{
  "html": "<table border=\"1px\" style=\"width: 100%;\"> <tbody><tr><td>&nbsp;</td>\n\t\t\t\t\t<th>PC Number</th>\n\t\t\t\t\t<th>Date</th>\n\t\t\t\t\t<th>Chapter</th>\n\t\t\t\t\t<th>Bill</th>\n\t\t\t\t\t<th>Dept</th></tr><tr><td style=\"min-width: 120px;\">&nbsp;</td><td>2016-0373</td><td>2016-05-20</td><td></td><td></td><td>,&nbsp; ,&nbsp; ,&nbsp; ,&nbsp; HC</td></tr><tr><td>Act</td><td colspan=\"5\">Controlled Drugs and Substances Act</td></tr><tr><td>Subject</td><td colspan=\"5\">Order Amending Schedules l and lll to the Controlled Drugs and Substances Act (AH-7921, MT-45, W-18 and Lefetamine)</td></tr><tr><td>Precis</td><td colspan=\"5\" id=\"precis\">Order Amending SCHEDULES I AND III TO THE CONTROLLED DRUGS AND SUBSTANCES ACT (AH- 7921, MT-45, W-18 AND LEFETAMINE) in order to add new entries to Schedule I to the CDSA for AH-7921 (and its salts, isomers and salts of isomers), as well as for MT-45 and W-18 (and their salts, derivatives, isomers, analogues, and salts of derivatives, isomers and analogues). These related substances are also known to have psychoactive effects so they are being scheduled along with their parent substance. In the interest of clarity, four analogues of MT-45 (DEP, MXP, NEDPA and NPDPA) will also be specifically listed under the entry for MT-45.</td></tr><tr><td>Registration</td><td colspan=\"5\" id=\"registration\"><strong>Registration: </strong>SOR/ 2016-0107  <strong>Publication Date:</strong> 2016-06-01</td></tr><tr><td>Attachments</td><td colspan=\"5\"><a href=\"attachment.php?attach=32053&amp;lang=en\">Attachment</a></td></tr></tbody></table>",
  "pcNumber": "2016-0373",
  "htmlHash": "ee80cda89f4007a1dad7b7876082d25b",
  "attachments": [
    "32053"
  ]
}